The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125379571 12537957 1 I 20151119 20160627 20160707 20160707 EXP DE-MYLANLABS-2016M1027346 MYLAN 0.00 Y 0.00000 20160707 CN DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125379571 12537957 1 PS ESCITALOPRAM ESCITALOPRAM OXALATE 1 Transplacental 10 [MG/D ]/ INTERMITTENTLY 7.5 MG/D FOR A SHORT TIME PERIOD. 77660 10 MG QD
125379571 12537957 2 SS DECORTIN-H /00016201/ PREDNISOLONE HEMISUCCINATE 1 Transplacental 5.5 [MG/D ]/ MINIMUM DOSAGE 5 MG/D 0 5.5 MG QD
125379571 12537957 3 C L-THYROXIN LEVOTHYROXINE SODIUM 1 Transplacental 75 [?G/D ] U 0 75 UG QD
125379571 12537957 4 C DEKRISTOL CHOLECALCIFEROL 1 Transplacental 1000 [IE/D ]/ PROBABLY TAKEN LONGER. REDUCTION TO 500 IE/D, STOPPED DURING THE 1ST TRIMESTER U 0 1000 IU QD
125379571 12537957 5 C CYTOTEC MISOPROSTOL 1 Transplacental U 0
125379571 12537957 6 C FEMIBION 1 2 Transplacental 0.8 [MG/D ] U 0 .8 MG QD
125379571 12537957 7 C AMPICILLIN AMPICILLIN 1 Transplacental UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125379571 12537957 1 Depression
125379571 12537957 2 Sarcoidosis
125379571 12537957 3 Hypothyroidism
125379571 12537957 4 Osteoporosis prophylaxis
125379571 12537957 5 Labour induction
125379571 12537957 6 Prophylaxis of neural tube defect
125379571 12537957 7 Infection prophylaxis

Outcome of event

Event ID CASEID OUTC COD
125379571 12537957 OT
125379571 12537957 CA

Reactions reported

Event ID CASEID DRUG REC ACT PT
125379571 12537957 Bradycardia neonatal
125379571 12537957 Congenital hydronephrosis
125379571 12537957 Foetal exposure during pregnancy
125379571 12537957 Kidney duplex
125379571 12537957 Respiratory disorder neonatal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125379571 12537957 1 20150310 20151119 0
125379571 12537957 2 20150310 20151119 0
125379571 12537957 3 20150310 20151119 0
125379571 12537957 4 20150310 20150413 0
125379571 12537957 5 20151119 20151119 0
125379571 12537957 7 20151119 20151119 0